Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Qnexa phentermine/topiramate: Phase III started

VVUS began a double-blind Phase III CONQUER (OB-303) trial in about 2,500 overweight and

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE